A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor
Clinical trial NCT05561036 · UNKNOWN
Trial details
- NCT number
- NCT05561036
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2022-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.